buffer outsourcing illustration

Explore custom formulation development to help streamline processes

Biomanufacturing has evolved from classical protein biologicals and vaccines to a diverse number of current products and therapeutics—such as mRNA vaccines, medical devices, and tissue, cell, and gene therapies. Approaches to buffer preparation has become more important of late due to this increase in product offerings, increases in volumetric productivity upstream, and developments in bioprocessing materials, processes, and facilities. Labor-intensive and inflexible buffer supply methods can impose financial and operational stress, as well as processing bottlenecks. We can help you streamline processes so you can focus on developing therapies to help meet growing population needs.

Expanding capacity and capabilities to help meet evolving biomanufacturing needs

Opening in summer of 2023, this 70% capacity expansion supports manufacturing of buffers and process liquids used in bioprocessing. The expansion helps meet the increasing global demand for more complex molecule development and increases the site’s capacity to produce critical raw materials used in the development and manufacturing of biologic therapies.

The way forward in buffer manufacturing

Expansion includes manufacturing Thermo Fisher Scientific's process liquids and buffers with capability for large volume liquids and cell culture media to help the development and commercial manufacturing of critical medicines.

The way forward with quality management

Quality you can rely on. We're focused on meeting your current and future requirements for outsourcing bulk liquids with the utmost commitment to quality and compliance with cGMP standards.

The way forward with supply assurance

Benefit from our global network of cGMP chemical raw materials from redundant supply base to help meet demand.

Get industry professional insights

Key resources

Bioprocessing resources

Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.